Talk:Liver tumor

From Wikipedia, the free encyclopedia

WikiProject Medicine This article is within the scope of WikiProject Medicine. Please visit the project page for details or ask questions at the doctor's mess.
Stub This page has been rated as stub-Class on the quality assessment scale
??? This page has not yet received a rating on the importance assessment scale.

I merged hepatic tumour to this article because I think this a more generally accesible page for this subject. --Steven Fruitsmaak 17:49, 22 May 2006 (UTC)

[edit] Suggested move

This page is more accurately titled "Liver tumor", because the article includes both benign and malignant tumors. Axl 16:37, 5 July 2007 (UTC)

  • Support. Not quite sure what liver cancer should then become:
    • Disambig to liver tumor and hepatocellular carcinoma
    • Redir to hepatocellular carcinoma
    • Redir to liver tumor - but in all cases, these articles need to point each to the other. Andrewa 04:16, 6 July 2007 (UTC)
Thanks, Andrew. Liver cancer should re-direct to hepatocellular carcinoma.Axl 09:14, 7 July 2007 (UTC)
  • Oppose - All articles on Wikipedia about cancer don't discuss the concept of the tumour, but the cancer itself. It also creates controversy over the BrE/AmE spelling. Reginmund 21:14, 8 July 2007 (UTC)
"All articles on Wikipedia about cancer don't discuss the concept of the tumour, but the cancer itself." That's because articles about cancer are, er, about cancer. That's exactly my point. "It also creates controversy over the BrE/AmE spelling." Numerous articles have one or other variant spelling. All that is required is a re-direct from the counterpart. Indeed "Tumour" re-directs to "Tumor". Axl 06:53, 9 July 2007 (UTC)

This article has been renamed from liver cancer to liver tumor as the result of a move request. --Stemonitis 23:34, 16 July 2007 (UTC)

[edit] "Antibody retards growth and induces death in liver cancer cells"

Using a newly available monoclonal antibody, they (University of Pittsburgh School of Medicine researchers) demonstrated significant reductions in tumor cell proliferation and survival in human and mouse hepatocellular cancer (HCC) cell lines. According to the researchers, this finding has significant implications not only for the treatment of liver cancer but for a number of different types of cancer. [1] Brian Pearson 02:30, 12 July 2007 (UTC)